The Fall of TRML Stock: Tourmaline Bio Posts Disappointing Q4 2023 Earnings

Published On: March 19, 2024 7:34 pm

TRML stock - TRML Stock Earnings: Tourmaline Bio Reported Results for Q4 2023

Source: iQoncept / Shutterstock

The once-promising Tourmaline Bio (NASDAQ:TRML) has just released its figures for the much-anticipated final quarter of 2023.

Shareholders were met with a bitter pill as Tourmaline Bio reported an earnings per share of -81 cents.
Even more alarming, the company disclosed a regrettably unsurprising fact – zero revenue for the said quarter.

Amalgamating data from TradeSmith, InvestorPlace Earnings has introduced a system that provides lightning-fast coverage of quarterly earnings reports. Distilling vital information such as earnings per share, revenue, and how a firm measures against analyst forecasts, these articles are churned out without a human touch to efficiently keep our readers in the know. For any discrepancies, whistle-blowers can reach out to us at [email protected].

Article printed from InvestorPlace Media, https://investorplace.com/earning-results/2024/03/trml-stock-earnings-tourmaline-bio-for-q4-of-2023/.

5 Stocks Our Experts Predict Could Double In the Next Year

By submitting your email, you'll also get a free pivot & flow membership. A free daily market overview. You can unsubscribe at any time.